In contrast, other CHIP-related genes, such as ASXL1 and TET2, were less frequently mutated in younger than in older NPM1-mut AML patients (1% vs. 4% and 17% vs. 27%, respectively) [44]. This evidence concerns the gene STUB1 and acute myeloid leukemia.